Full Press Release Details
Dr. Garrison joined Senti Bio in 2016, where he has continually applied his 25 years of cell & gene therapy experience towards the successful development and clinical application of Senti’s Gene Circuit technologies to develop truly innovative medicines with the ability to target diseases in a more focused, controlled, and effective manner. Dr. Garrison currently leads both the Discovery Research and Translational Science Teams at Senti.
Dr. Garrison earned his B.S. in Microbiology (minor: Comparative Literature) from University of California, Davis, and a Ph.D. in human gene therapy from Stanford University, then completed 2 postdoctoral fellowships (Harvard University & Harvard Medical School) focused on stem cell biology, leukemia, genome editing, and TGFβ, with numerous high impact publications, fellowship, grant, and contract awards.